Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2011
06/23/2011US20110152720 Sample preparation methods and systems
06/23/2011US20110152358 Compositions and Methods for Diagnosis and Treatment of Pancreatic Ductal Cancer
06/23/2011US20110152357 Micro-RNA-Based Compositions and Methods for the Diagnosis, Prognosis and Treatment of Multiple Myeloma
06/23/2011US20110152346 Use of Oligonucleotides with Modified Bases in Hybridization of Nucleic Acids
06/23/2011US20110152345 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis
06/23/2011US20110152301 Compounds that Inhibit HIV Particle Formation
06/23/2011US20110152291 Novel aromatic compounds and their use in medical applications
06/23/2011US20110152224 Myeloperoxidase, a risk indicator for cardiovascular disease
06/23/2011US20110152220 Methods of diagnosing, preventing and treating bone mass diseases
06/23/2011US20110152215 Riboswitches, methods for their use, and compositions for use with riboswitches
06/23/2011US20110152170 Use of Procalcitonin (PCT) in Risk Stratification and Prognosis of Patients with a Primary, Non-Infectious Disease
06/23/2011US20110152166 Method of modulation of protein phosphorylation-dependent conformational transitions with low molecular weight compounds
06/23/2011US20110152129 Sample well strip
06/23/2011US20110152123 Cellular screening substratum and manufacturing process for it, and method and apparatus for cellular screening with it
06/23/2011US20110152122 Compositions and Methods for the Identification and Use of Epigenetic Markers Useful in the Study of Normal and Abnormal Mammalian Gametogenesis
06/23/2011US20110152118 Method and system for determination of molecular interaction parameters
06/23/2011US20110152117 Methods of determining efficacy of treatments of diseases of the bowel
06/23/2011US20110152110 Set of Tumour-Markers
06/23/2011US20110152107 Drug Screening Via Nanpore Silicon Filters
06/23/2011US20110152106 Cst1, dcc1, ifitm1 or melk as markers for diagnosing stomach cancer
06/23/2011US20110151586 Polymer encapsulated particles as surface enhanced raman scattering probes
06/23/2011US20110151585 Dual inlet microchannel device and method for using same
06/23/2011US20110151584 Dual Path Immunoassay Device
06/23/2011US20110151583 Method for evaluating myocardial ischemic state using blood sample
06/23/2011US20110151582 Method for detection of antigen-specific antibodies in biological samples
06/23/2011US20110151581 Trigger assay for differentiating between rheumatic and non-rheumatic disorders
06/23/2011US20110151580 Method for the detection of breast cancer by determining alcam and/or bcam levels in a patient
06/23/2011US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof
06/23/2011US20110151577 Disposable device for automated biological sample preparation
06/23/2011US20110151573 Nanoporous Detectors of Monocyclic Aromatic Compounds and Other Pollutants
06/23/2011US20110151572 Method, device and apparatus for measuring the concentration of creatinine, and method, device and apparatus for measuring the amount of salt in urine using the same
06/23/2011US20110151571 Memory apparatus for multiuse analyte test element systems, and kits, systems, combinations and methods relating to same
06/23/2011US20110151570 Method for on-site drug detection in illicit drug samples
06/23/2011US20110151569 Identification of sample components
06/23/2011US20110151568 Assay for Monitoring Parathyroid Hormone (PTH) Variants by Tandem Mass Spectrometry
06/23/2011US20110151549 Device For Carrying Out An Individual Immunoassay In A Fully Automatic Manner
06/23/2011US20110151499 Apparatus and methods for conducting assays and high throughput screening
06/23/2011US20110151498 Apparatus and methods for conducting assays and high throughput screening
06/23/2011US20110151497 Metabolomic profiling of prostate cancer
06/23/2011US20110151494 Methods and materials for monitoring myeloma using quantitative mass spectrometry
06/23/2011US20110151493 Polypeptide disulfide bond analysis
06/23/2011US20110151490 Compositions for the Detection and Treatment of Colorectal Cancer
06/23/2011US20110151489 Monitoring skin metabolism products for evaluating burn injury
06/23/2011US20110151488 Detection and monitoring of liver damage
06/23/2011US20110151487 Compositions And Methods For The Treatment Of Cancer
06/23/2011US20110151486 Methods and systems to prevent gas bubbles from interfering with flow of fluid through a membrane region
06/23/2011US20110151485 Method for screening for antiangiogenic agent, and method for screening for antiangiogenic signal gene
06/23/2011US20110151484 hERG MUTANTS AND USES THEREOF
06/23/2011US20110151483 Mammalian Sweet and Amino Acid Heterodimeric Taste Receptors Comprising T1R3 and T1R1
06/23/2011US20110151482 Automated developer for immuno-stained biological samples
06/23/2011US20110151481 Beta-2 microglobulin as a biomarker for peripheral artery disease
06/23/2011US20110151480 Methods of purifying zsig33
06/23/2011US20110151479 Microfluidic systems incorporating flow-through membranes
06/23/2011US20110151478 Transcriptional biomarkers and methods for detecting and isolating cancer cells in body fluids and tissue specimens
06/23/2011US20110151477 Methods for detecting antibodies in mucosal samples and device for sampling mucosal material
06/23/2011US20110151476 Method of detection and/or titration in vitro of an unconventional transmissible agent
06/23/2011US20110151475 Lab-on-a-chip and method of driving the same
06/23/2011US20110151473 Polynucleotides and Polypeptides Encoding Receptors
06/23/2011US20110151472 Novel means for the diagnosis and therapy of ctcl
06/23/2011US20110151469 Interferon epsilon (ifne1) as a marker for targeted cancer therapy
06/23/2011US20110151460 Methods and systems of using exosomes for determining phenotypes
06/23/2011US20110151454 Gene expression markers of tumor resistance to HER2 inhibitor treatment
06/23/2011US20110151436 Compositions and methods for the detection of hiv-1/hiv-2 infection
06/23/2011US20110151435 Novel assays for detecting analytes in samples and kits and compositions related thereto
06/23/2011US20110151433 Methods for production of unstructured recombinant polymers and uses thereof
06/23/2011US20110151432 Methods and systems to collect and prepare samples, to implement, initiate and perform assays, and to control and manage fluid flow
06/23/2011US20110151429 Bioprobe, Method of Preparing the Bioprobe, and Analysis Apparatus and Method Using the Bioprobe
06/23/2011US20110151073 Systems and Methods for Ozone Treatment of Grain in Grain Piles
06/23/2011US20110150935 Targeted treatment for patients with estrogen receptor negative and progesterone receptor negative breast cancers
06/23/2011US20110150920 Allergy Vaccines Containing Hybrid Polypeptides
06/23/2011US20110150919 Compositions and methods for the therapy and diagnosis of breast cancer
06/23/2011US20110150916 Compositions and methods for treatment of group a streptococci
06/23/2011US20110150910 Methods of inducing an immune response
06/23/2011US20110150900 Regulation of fatty acid transporters
06/23/2011US20110150897 Influenza targets
06/23/2011US20110150895 Antibody specifically binding to angiopoietin-2 and use thereof
06/23/2011US20110150893 Anti-trkb monoclonal antibodies and uses thereof
06/23/2011US20110150890 Use of cgrp antagonist compounds for treatment of psoriasis
06/23/2011US20110150889 Haemophilus influenzae type iv pili
06/23/2011US20110150884 Crystalline composition of gm-csf/gm-csfr
06/23/2011US20110150883 Compositions and methods for the therapy and diagnosis of breast cancer
06/23/2011US20110150882 Compositions and methods for the therapy and diagnosis of ovarian cancer
06/23/2011US20110150881 Inhibitors of extracellular hsp90
06/23/2011US20110150877 Ephrin-b receptor protein involved in carcinoma
06/23/2011US20110150876 Prognosis and Treatment of Breast Cancer
06/23/2011US20110150875 Egf-a domain-mediated modulation of pcks9 for treating lipid disorders
06/23/2011US20110150868 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
06/23/2011US20110150866 Compositions and Methods for Increasing Bone Mineralization
06/23/2011US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
06/23/2011US20110150780 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
06/23/2011US20110150774 Screening for modulators of ces1 and/or ces3 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
06/23/2011US20110150773 Modulators of acetyl-coenzyme a acyltransferase 1 or 2 in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
06/23/2011US20110150772 Modulators of carnitine octanoyltransferase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
06/23/2011US20110150760 PRLR-Specific Antibody and Uses Thereof
06/23/2011US20110150759 Monoclonal antibody 175 tageting the egf receptor and derivatives and uses thereof
06/23/2011US20110150705 Integrated Hinged Cartridge Housings for Sample Analysis
06/23/2011US20110150704 Container having gas scrubber insert for automated clinical analyzer
06/23/2011US20110150703 Tortuous path static mixers and fluid systems including the same
06/23/2011US20110150702 Microfluidic device and method of manufacturing the same
06/23/2011US20110150701 Chemical sensor using metal nano-particles and method for manufacturing chemical sensor using metal nano-particles